Details of the Drug Reposition

General Information of This Drug (ID: DMFN1WI)

• Drug Name: BR3-Fc (DMFN1WI)

Information on Drug Reposition of This Drug

2 Discontinued in Phase 2 Indication(s)

Indication Name	Indication ID	ICD-11	Status	REF
Idiopathic thrombocytopenic purpura	DISFKGJU	3B64.10	Discontinued in Phase 2	[1]
Rheumatoid arthritis	DISTSB4J	FA20	Discontinued in Phase 2	[1]

References

• [1] Emerging drugs for idiopathic thrombocytopenic purpura in adults. Expert Opin Emerg Drugs. 2008 Jun;13(2):237-54.